MARÍA SIMARRO

Dr. MARÍA SIMARRO

Department of Nursing, University of Valladolid, 47005 Valladolid, Spain

Research Focus & Metrics

Academic Career Length

31Years (1996-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 January 2003 in Nature Cell Biology
Verified
Journal Article
Closed access
BCBetty Chan
Betty Chan
ALArpad Lanyi
Arpad Lanyi
HSHyun Kyu Song
Hyun Kyu Song
JGJan Griesbach
Jan Griesbach
MSMARÍA SIMARRO
MARÍA SIMARRO
MEMichael J. Eck
Michael J. Eck

1 April 2001 in Annual Review of Immunology
Verified
Journal Article
Closed access
MMMassimo Morra
Massimo Morra
DHDuncan Howie
Duncan Howie
MSMARÍA SIMARRO
MARÍA SIMARRO
JSJoan Sayos
Joan Sayos
NWNinghai Wang
Ninghai Wang
CTCox Terhorst
Cox Terhorst
Our understanding of the X-linked lymphoproliferative syndrome (XLP) has advanced significantly in the last two years. The gene that is altered in the condition (SAP/SH2D1A) has been cloned and its protein crystal structure solved. At least two sets of target molecules for this small SH2 domain-containing protein have been identified: A family of hematopoietic cell surface receptors, i.e. the SLAM family, and a second molecule, which is a phosphorylated adapter. A SAP-like protein, EAT-2, has also been found to interact with this family of surface receptors. Several lines of evidence, including structural studies and analyses of missense mutations in XLP patients, support the notion that SAP/SH2D1A is a natural inhibitor of SH2-domain-dependent interactions with members of the SLAM family. However, details of its role in signaling mechanisms are yet to be unravelled. Further analyses of the SAP/SH2D1A gene in XLP patients have made it clear that the development of dys-gammaglobulinemia and B cell lymphoma can occur without evidence of prior EBV infection. Moreover, preliminary results of virus infections of a mouse in which the SAP/SH2D1A gene has been disrupted suggest that EBV infection is not per se critical for the development of XLP phenotypes. It appears therefore that the SAP/SH2D1A gene controls signaling via the SLAM family of surface receptors and thus may play a fundamental role in T cell and APC interactions during viral infections.

31 January 2011 in European Journal of Immunology
Verified
Journal Article
Open access
PDF file
MSMaria del Carmen Sancho‐Serra
Maria del Carmen Sancho‐Serra
MSMARÍA SIMARRO
MARÍA SIMARRO
MCMariana Castells
Mariana Castells
Rapid IgE desensitization provides temporary tolerization for patients who have presented severe hypersensitivity reactions to food and drugs, protecting them from anaphylaxis, but the underlying mechanisms are still incompletely understood. Thus, here we develop an effective and reproducible in vitro model of rapid IgE desensitization for mouse BM‐derived mast cells (BMMCs) under physiologic calcium conditions, and we characterize its antigen specificity and primary events. BMMCs were challenged with DNP‐human serum albumin conjugated (DNP‐HSA) and/or OVA antigens, delivered either as a single dose (activation) or as increasing sequential doses (desensitization). Compared to activated cells, desensitized BMMCs had impaired degranulation, calcium flux, secretion of arachidonic acid products, early and late TNF‐α production, IL‐6 production, and phosphorylation of STAT6 and p38 mitogen‐activated protein kinase (p38 MAPK). OVA‐desensitized cells responded to DNP and DNP‐desensitized cells responded to OVA, proving specificity. Internalization of specific antigen, IgE and high‐affinity receptor for IgE (FcεRI) were impaired in desensitized BMMCs. Our results demonstrate that rapid IgE desensitization is antigen specific and inhibits early and late mast cell activation responses and internalization of the antigen/IgE/FcεRI complexes.

15 June 2001 in Blood
Verified
Journal Article
Closed access
PDF file
JSJoan Sayós
Joan Sayós
MMMarga Martín
Marga Martín
ACAlice Chen
Alice Chen
MSMARÍA SIMARRO
MARÍA SIMARRO
DHDuncan Howie
Duncan Howie
CTCox Terhorst
Cox Terhorst
X-linked lymphoproliferative disease (XLP) is a rare immune disorder commonly triggered by infection with Epstein-Barr virus. Major disease manifestations include fatal acute infectious mononucleosis, B-cell lymphoma, and progressive dys-gammaglobulinemia. SAP/SH2D1A, the product of the gene mutated in XLP, is a small protein that comprises a single SH2 domain and a short tail of 26 amino acids. SAP binds to a specific motif in the cytoplasmic tails of the cell surface receptors SLAM and 2B4, where it blocks recruitment of the phosphatase SHP-2. Here it is reported that Ly-9 and CD84, 2 related glycoproteins differentially expressed on hematopoietic cells, also recruit SAP. Interactions between SAP and Ly-9 or CD84 were analyzed using a novel yeast 2-hybrid system, by COS cell transfections and in lymphoid cells. Recruitment of SAP is most efficient when the specific tyrosine residues in the cytoplasmic tails of Ly-9 or CD84 are phosphorylated. It is concluded that in activated T cells, the SAP protein binds to and regulates signal transduction events initiated through the engagement of SLAM, 2B4, CD84, and Ly-9. This suggests that combinations of dysfunctional signaling pathways initiated by these 4 cell surface receptors may cause the complex phenotypes of XLP.

1 February 2015 in Cell Reports
Verified
Journal Article
Open access
AJAlexis A. Jourdain
Alexis A. Jourdain
MKMirko Koppen
Mirko Koppen
CRChristopher D. Rodley
Christopher D. Rodley
KMKinsey Maundrell
Kinsey Maundrell
NGNaïg Gueguen
Naïg Gueguen
JMJean-claude Martinou
Jean-claude Martinou
The mitochondrial genome relies heavily on post-transcriptional events for its proper expression, and misregulation of this process can cause mitochondrial genetic diseases in humans. Here, we report that a novel translational variant of Fas-activated serine/threonine kinase (FASTK) co-localizes with mitochondrial RNA granules and is required for the biogenesis of ND6 mRNA, a mitochondrial-encoded subunit of the NADH dehydrogenase complex (complex I). We show that ablating FASTK expression in cultured cells and mice results specifically in loss of ND6 mRNA and reduced complex I activity in vivo. FASTK binds at multiple sites along the ND6 mRNA and its precursors and cooperates with the mitochondrial degradosome to ensure regulated ND6 mRNA biogenesis. These data provide insights into the mechanism and control of mitochondrial RNA processing within mitochondrial RNA granules.

19 September 2017 in Nucleic Acids Research
Verified
Journal Article
Open access
PDF file
AJAlexis A. Jourdain
Alexis A. Jourdain
JPJohannes Popow
Johannes Popow
MFMiguel Angel de la fuente
Miguel Angel de la fuente
JMJean-claude Martinou
Jean-claude Martinou
PAPaul Anderson
Paul Anderson
MSMARÍA SIMARRO
MARÍA SIMARRO
The FASTK family proteins have recently emerged as key post-transcriptional regulators of mitochondrial gene expression. FASTK, the founding member and its homologs FASTKD1–5 are architecturally related RNA-binding proteins, each having a different function in the regulation of mitochondrial RNA biology, from mRNA processing and maturation to ribosome assembly and translation. In this review, we outline the structure, evolution and function of these FASTK proteins and discuss the individual role that each has in mitochondrial RNA biology. In addition, we highlight the aspects of FASTK research that still require more attention.